应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ALDX Aldeyra Therapeutics Inc
未开盘 09-17 16:00:00 EDT
5.78
-0.13
-2.20%
盘后
5.78
+0.00
0.00%
16:14 EDT
最高
5.99
最低
5.69
成交量
32.71万
今开
5.99
昨收
5.91
日振幅
5.08%
总市值
3.43亿
流通市值
2.49亿
总股本
5,942万
成交额
189.29万
换手率
0.76%
流通股本
4,313万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Aldeyra Therapeutics, Inc.盘中异动 急速上涨5.13%报5.33美元
自选股智能写手 · 08-19
Aldeyra Therapeutics, Inc.盘中异动 急速上涨5.13%报5.33美元
Aldeyra Therapeutics, Inc.盘中异动 股价大涨5.33%报4.94美元
自选股智能写手 · 08-15
Aldeyra Therapeutics, Inc.盘中异动 股价大涨5.33%报4.94美元
Aldeyra Therapeutics, Inc.盘中异动 大幅上涨5.01%
自选股智能写手 · 08-09
Aldeyra Therapeutics, Inc.盘中异动 大幅上涨5.01%
BUZZ--美国股票走势-Datadog、Palantir、NRG 能源公司
Reuters · 08-08
BUZZ--美国股票走势-Datadog、Palantir、NRG 能源公司
BUZZ-眼病疗法达到后期研究目标,Aldeyra公司业绩上升
Reuters · 08-08
BUZZ-眼病疗法达到后期研究目标,Aldeyra公司业绩上升
Aldeyra Therapeutics, Inc.盘中异动 大幅跳水5.23%
自选股智能写手 · 08-08
Aldeyra Therapeutics, Inc.盘中异动 大幅跳水5.23%
Aldeyra Therapeutics, Inc.盘中异动 股价大涨5.74%报3.41美元
自选股智能写手 · 08-07
Aldeyra Therapeutics, Inc.盘中异动 股价大涨5.74%报3.41美元
Aldeyra Therapeutics, Inc.盘中异动 大幅下挫5.93%报3.49美元
自选股智能写手 · 08-02
Aldeyra Therapeutics, Inc.盘中异动 大幅下挫5.93%报3.49美元
Aldeyra Therapeutics Inc 预计每股亏损 15 美分 - 财报前瞻
Reuters · 07-31
Aldeyra Therapeutics Inc 预计每股亏损 15 美分 - 财报前瞻
Aldeyra Therapeutics, Inc.盘中异动 临近收盘股价大跌5.06%
自选股智能写手 · 07-30
Aldeyra Therapeutics, Inc.盘中异动 临近收盘股价大跌5.06%
Aldeyra Therapeutics, Inc.盘中异动 股价大涨5.17%报4.07美元
自选股智能写手 · 07-23
Aldeyra Therapeutics, Inc.盘中异动 股价大涨5.17%报4.07美元
Aldeyra Therapeutics, Inc.盘中异动 股价大跌5.41%
自选股智能写手 · 07-19
Aldeyra Therapeutics, Inc.盘中异动 股价大跌5.41%
Aldeyra Therapeutics, Inc.盘中异动 股价大涨5.05%报4.16美元
自选股智能写手 · 07-17
Aldeyra Therapeutics, Inc.盘中异动 股价大涨5.05%报4.16美元
Aldeyra Therapeutics, Inc.盘中异动 急速下跌6.06%报3.41美元
自选股智能写手 · 06-20
Aldeyra Therapeutics, Inc.盘中异动 急速下跌6.06%报3.41美元
Aldeyra Therapeutics, Inc.盘中异动 下午盘股价大跌5.18%报3.66美元
自选股智能写手 · 06-15
Aldeyra Therapeutics, Inc.盘中异动 下午盘股价大跌5.18%报3.66美元
Aldeyra Therapeutics Inc:临床试验结果和新药申请再次提交预计在2024年下半年公布。
智通财经 · 06-13
Aldeyra Therapeutics Inc:临床试验结果和新药申请再次提交预计在2024年下半年公布。
Aldeyra Therapeutics, Inc.盘中异动 早盘快速上涨5.54%
自选股智能写手 · 06-12
Aldeyra Therapeutics, Inc.盘中异动 早盘快速上涨5.54%
Aldeyra Therapeutics, Inc.盘中异动 临近收盘股价大跌5.02%
自选股智能写手 · 06-07
Aldeyra Therapeutics, Inc.盘中异动 临近收盘股价大跌5.02%
Aldeyra Therapeutics, Inc.盘中异动 早盘快速拉升5.47%报4.05美元
自选股智能写手 · 06-04
Aldeyra Therapeutics, Inc.盘中异动 早盘快速拉升5.47%报4.05美元
Aldeyra Therapeutics, Inc.盘中异动 快速跳水5.12%报3.71美元
自选股智能写手 · 05-29
Aldeyra Therapeutics, Inc.盘中异动 快速跳水5.12%报3.71美元
加载更多
公司概况
公司名称:
Aldeyra Therapeutics Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Aldeyra Therapeutics, Inc.是一家2004年8月13日成立于特拉华州的神经系统股份有限公司。公司为生物技术公司,专注于开发产品用以治疗免疫介导、相关炎症、罕见病症以及其他与游离醛(一种自然产生的有害化学物质)相关的疾病。Aldeyra Therapeutics正在开发下一代药物,以改善免疫介导疾病患者的生活。 Aldeyra的主要产品候选药物reproxalap是干眼症和其他形式眼炎症晚期发展的一流治疗药物。 Aldeyra还在开发自身免疫性疾病,移植后淋巴组织增生性疾病,视网膜炎症,代谢性疾病和癌症的其他候选产品。 Aldeyra的产品候选人均未获准在美国或其他地方销售。
发行价格:
--
{"stockData":{"symbol":"ALDX","market":"US","secType":"STK","nameCN":"Aldeyra Therapeutics Inc","latestPrice":5.78,"timestamp":1726603200000,"preClose":5.91,"halted":0,"volume":327090,"hourTrading":{"tag":"盘后","latestPrice":5.78,"preClose":5.78,"latestTime":"16:14 EDT","volume":4122,"amount":23825,"timestamp":1726604097510},"delay":0,"floatShares":43131614,"shares":59421551,"eps":-0.639098,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.13,"latestTime":"09-17 16:00:00 EDT","open":5.99,"high":5.99,"low":5.69,"amount":1892897.63265,"amplitude":0.050761,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.639098,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1726646400000},"adr":0,"listingDate":1399003200000,"adjPreClose":5.91,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":6.06,"preClose":5.91,"latestTime":"09:07 EDT","volume":1,"amount":6.06,"timestamp":1726578460358},"postHourTrading":{"tag":"盘后","latestPrice":5.78,"preClose":5.78,"latestTime":"16:14 EDT","volume":4122,"amount":23825,"timestamp":1726604097510},"volumeRatio":0.7415016010647361,"impliedVol":1.0333,"impliedVolPercentile":0.2789},"requestUrl":"/m/hq/s/ALDX","defaultTab":"news","newsList":[{"id":"2460342590","title":"Aldeyra Therapeutics, Inc.盘中异动 急速上涨5.13%报5.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460342590","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460342590?lang=zh_cn&edition=full","pubTime":"2024-08-19 21:36","pubTimestamp":1724074600,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日21时36分,Aldeyra Therapeutics, Inc.股票出现波动,股价大幅拉升5.13%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.28%。其相关个股中,Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Geovax Labs Inc C/Wts 29/09/2025涨幅较大,Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Cingulate Inc.较为活跃,换手率分别为2525.35%、1448.33%、350.40%,振幅较大的相关个股有Alzamend Neuro, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Virax Biolabs Group Limited,振幅分别为82.83%、70.11%、41.78%。Aldeyra Therapeutics, Inc.公司简介:Aldeyra Therapeutics Inc是一家生物技术公司,致力于开发和商业化下一代药物,以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921364097199210&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921364097199210&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALDX","LENZ","BK4139"],"gpt_icon":0},{"id":"2459427495","title":"Aldeyra Therapeutics, Inc.盘中异动 股价大涨5.33%报4.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459427495","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459427495?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:31","pubTimestamp":1723728689,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时31分,Aldeyra Therapeutics, Inc.股票出现波动,股价快速上涨5.33%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.61%。其相关个股中,Cingulate Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Nutriband Inc C/Wts 涨幅较大,Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃,换手率分别为2342.61%、1457.61%、336.08%,振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Cingulate Inc.、Geovax Labs, Inc.,振幅分别为32.31%、28.18%、10.46%。Aldeyra Therapeutics, Inc.公司简介:Aldeyra Therapeutics Inc是一家生物技术公司,致力于开发和商业化下一代药物,以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213129ab5dd831&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213129ab5dd831&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALDX","BK4139","LENZ"],"gpt_icon":0},{"id":"2458595948","title":"Aldeyra Therapeutics, Inc.盘中异动 大幅上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458595948","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458595948?lang=zh_cn&edition=full","pubTime":"2024-08-09 21:32","pubTimestamp":1723210361,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日21时32分,Aldeyra Therapeutics, Inc.股票出现波动,股价快速上涨5.01%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.25%。其相关个股中,Pasithea Therapeutics Corp C/Wts 12/08/2026 、Adma Biologics Inc、Third Harmonic Bio, Inc.涨幅较大,Conduit Pharmaceuticals Inc.、Cns Pharmaceuticals, Inc.、Aditxt, Inc.较为活跃,换手率分别为34.18%、5.41%、5.32%,振幅较大的相关个股有Conduit Pharmaceuticals Inc.、An2 Therapeutics, Inc.、Avidity Biosciences, Inc.,振幅分别为15.53%、12.25%、10.46%。Aldeyra Therapeutics, Inc.公司简介:Aldeyra Therapeutics Inc是一家生物技术公司,致力于开发和商业化下一代药物,以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408092132419682573d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408092132419682573d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ALDX"],"gpt_icon":0},{"id":"2457561316","title":"BUZZ--美国股票走势-Datadog、Palantir、NRG 能源公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2457561316","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457561316?lang=zh_cn&edition=full","pubTime":"2024-08-08 21:29","pubTimestamp":1723123759,"startTime":"0","endTime":"0","summary":" * 个股走势的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 8月8日 - 美国股指期货周四涨跌不一,投资者在就业报告公布前转为谨慎,上周的经济数据弱于预期,引发了对经济衰退的担忧。美东时间9:10 ,道指电子盘 上涨0.34%,报39,036 点。标普500指数小型股 上涨0.89%,报5274.25点;纳斯达克100指数小型股 上涨1.20%,报18182.25点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BK4W5M84.HKD","LU1267930730.SGD","BK4504","BK4125","BMBL","LU0672654240.SGD","PLTR","IE00B2B36J28.USD","LU0198837287.USD","BK4543","SGXZ81514606.USD","BUZZ","BK4139","LU2286300806.USD","SEDG","LU0456855351.SGD","IE00B4R5TH58.HKD","LU2326559502.SGD","LU0106261372.USD","BK4532","LU1064131342.USD","BK4547","LU0345774631.USD","VTRS","UAA","NRG","LU0320765059.SGD","LU0640476718.USD","MNST","BK4588","LU0471298777.SGD","LU0345774391.USD","LU0256863902.USD","DDOG","LU0289739699.SGD","BK4167","BK4581","WBD","BK4023","PGEN","LU0238689110.USD","IE00BK4W5L77.USD","SGXZ99366536.SGD","LU0417517546.SGD","ALDX","GDRX","LU1023059063.AUD"],"gpt_icon":1},{"id":"2457927392","title":"BUZZ-眼病疗法达到后期研究目标,Aldeyra公司业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2457927392","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457927392?lang=zh_cn&edition=full","pubTime":"2024-08-08 20:08","pubTimestamp":1723118917,"startTime":"0","endTime":"0","summary":" 8月8日 - ** 药物开发商Aldeyra Therapeutics 股价盘前上涨10.4%至3.60美元 ** 该公司称其治疗干眼症的实验疗法达到了后期研究的主要目标** 干眼病会影响覆盖角膜的泪液层,导致灼热、瘙痒和视力模糊等症状 ** 公司称,从统计学角度看,该疗法 reproxalap 在减轻患者眼部不适症状方面更具优势 ** 试验旨在满足美国 FDA 重新提交上市申请的要求 - co ** 临床试验中未发现任何安全信号,患者对 reproxalap 的耐受性良好--ALDX ** FDA 去年否决了该疗法,因为它在治疗该疾病症状方面未显示出疗效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALDX","BUZZ"],"gpt_icon":0},{"id":"2457229658","title":"Aldeyra Therapeutics, Inc.盘中异动 大幅跳水5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457229658","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457229658?lang=zh_cn&edition=full","pubTime":"2024-08-08 00:50","pubTimestamp":1723049435,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日00时50分,Aldeyra Therapeutics, Inc.股票出现异动,股价急速下挫5.23%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为2.19%。其相关个股中,G1 Therapeutics, Inc.、Tc Biopharm Plc C/Wts 10/02/2028 、Aditxt, Inc.涨幅较大,Aditxt, Inc.、Salarius Pharmaceuticals, Inc.、Scorpius Holdings, Inc.较为活跃,换手率分别为4944.28%、1693.30%、326.10%,振幅较大的相关个股有Aditxt, Inc.、Tc Biopharm Plc C/Wts 10/02/2028 、Salarius Pharmaceuticals, Inc.,振幅分别为101.30%、69.66%、55.91%。Aldeyra Therapeutics, Inc.公司简介:Aldeyra Therapeutics Inc是一家生物技术公司,致力于开发和商业化下一代药物,以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808005036af966cfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808005036af966cfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALDX","LENZ","BK4139"],"gpt_icon":0},{"id":"2457766078","title":"Aldeyra Therapeutics, Inc.盘中异动 股价大涨5.74%报3.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457766078","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457766078?lang=zh_cn&edition=full","pubTime":"2024-08-07 00:12","pubTimestamp":1722960755,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日00时12分,Aldeyra Therapeutics, Inc.股票出现波动,股价急速上涨5.74%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.76%。Aldeyra Therapeutics, Inc.公司简介:Aldeyra Therapeutics Inc是一家生物技术公司,致力于开发和商业化下一代药物,以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807001236941feaa2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807001236941feaa2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALDX","LENZ","BK4139"],"gpt_icon":0},{"id":"2456289263","title":"Aldeyra Therapeutics, Inc.盘中异动 大幅下挫5.93%报3.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456289263","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456289263?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:30","pubTimestamp":1722605424,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时30分,Aldeyra Therapeutics, Inc.股票出现异动,股价快速下跌5.93%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.92%。其相关个股中,Exicure, Inc.、Anew Medical Inc C/Wts 21/06/2029 、Moleculin Biotech, Inc.涨幅较大,Exicure, Inc.、Dermata Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为213.34%、37.43%、14.12%,振幅较大的相关个股有Xencor, Inc.、Adaptimmune Therapeutics Plc、Trevena, Inc.,振幅分别为8.12%、3.93%、3.27%。Aldeyra Therapeutics, Inc.公司简介:Aldeyra Therapeutics Inc是一家生物技术公司,致力于开发和商业化下一代药物,以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213024aefcf7f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213024aefcf7f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ALDX"],"gpt_icon":0},{"id":"2455666948","title":"Aldeyra Therapeutics Inc 预计每股亏损 15 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2455666948","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455666948?lang=zh_cn&edition=full","pubTime":"2024-07-31 09:34","pubTimestamp":1722389663,"startTime":"0","endTime":"0","summary":" * Aldeyra Therapeutics Inc 预计在8月1日发布业绩报告时,季度营收将不会有任何变化。* * LSEG 分析师对 Aldeyra Therapeutics Inc 的平均预期是每股亏损 15 美分。* 华尔街对 Aldeyra Therapeutics Inc 的 12 个月目标价中位数为 10.00 美元,高于其上次收盘价 3.95 美元。7月31日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ALDX"],"gpt_icon":0},{"id":"2455181896","title":"Aldeyra Therapeutics, Inc.盘中异动 临近收盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455181896","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455181896?lang=zh_cn&edition=full","pubTime":"2024-07-30 03:34","pubTimestamp":1722281657,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日03时34分,Aldeyra Therapeutics, Inc.股票出现波动,股价大幅下挫5.06%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.15%。其相关个股中,Lipella Pharmaceuticals Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Geovax Labs Inc C/Wts 29/09/2025涨幅较大,Lipella Pharmaceuticals Inc.、Salarius Pharmaceuticals, Inc.、Windtree Therapeutics, Inc.较为活跃,换手率分别为2513.11%、1019.08%、272.85%,振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Nls Pharmaceutics Ltd.、Anew Medical Inc C/Wts 21/06/2029 ,振幅分别为170.75%、90.68%、57.78%。Aldeyra Therapeutics, Inc.公司简介:Aldeyra Therapeutics Inc是一家生物技术公司,致力于开发和商业化下一代药物,以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730033418941fb945&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730033418941fb945&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALDX","BK4139","LENZ"],"gpt_icon":0},{"id":"2453430059","title":"Aldeyra Therapeutics, Inc.盘中异动 股价大涨5.17%报4.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453430059","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453430059?lang=zh_cn&edition=full","pubTime":"2024-07-23 23:15","pubTimestamp":1721747724,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日23时15分,Aldeyra Therapeutics, Inc.股票出现波动,股价急速拉升5.17%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.34%。其相关个股中,Azitra Inc、Salarius Pharmaceuticals, Inc.、Adial Pharmaceuticals, Inc涨幅较大,Salarius Pharmaceuticals, Inc.、Azitra Inc、Adial Pharmaceuticals, Inc较为活跃,换手率分别为5436.86%、4897.91%、3303.47%,振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Azitra Inc、Adial Pharmaceuticals, Inc,振幅分别为366.13%、365.43%、137.74%。Aldeyra Therapeutics, Inc.公司简介:Aldeyra Therapeutics Inc是一家生物技术公司,致力于开发和商业化下一代药物,以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723231525941f9abf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723231525941f9abf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALDX","BK4139","LENZ"],"gpt_icon":0},{"id":"2452588864","title":"Aldeyra Therapeutics, Inc.盘中异动 股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452588864","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452588864?lang=zh_cn&edition=full","pubTime":"2024-07-19 02:12","pubTimestamp":1721326342,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日02时12分,Aldeyra Therapeutics, Inc.股票出现异动,股价急速下挫5.41%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为2.18%。其相关个股中,Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Onconetix, Inc.、Salarius Pharmaceuticals, Inc.涨幅较大,Salarius Pharmaceuticals, Inc.、Silo Pharma, Inc.、Onconetix, Inc.较为活跃,换手率分别为2916.76%、2547.51%、1286.14%,振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.,振幅分别为93.33%、91.50%、86.24%。Aldeyra Therapeutics, Inc.公司简介:Aldeyra Therapeutics Inc是一家生物技术公司,致力于开发和商业化下一代药物,以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719021222af9301c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719021222af9301c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ALDX","BK4139"],"gpt_icon":0},{"id":"2452176539","title":"Aldeyra Therapeutics, Inc.盘中异动 股价大涨5.05%报4.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452176539","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452176539?lang=zh_cn&edition=full","pubTime":"2024-07-17 00:25","pubTimestamp":1721147148,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日00时25分,Aldeyra Therapeutics, Inc.股票出现波动,股价快速拉升5.05%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.08%。其相关个股中,Silo Pharma, Inc.、Nutriband Inc C/Wts 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大,Silo Pharma, Inc.、Scisparc Ltd.、Virpax Pharmaceuticals, Inc.较为活跃,换手率分别为3413.48%、1276.37%、382.07%,振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Nutriband Inc C/Wts 、Virpax Pharmaceuticals, Inc.,振幅分别为79.41%、70.56%、61.68%。Aldeyra Therapeutics, Inc.公司简介:Aldeyra Therapeutics Inc是一家生物技术公司,致力于开发和商业化下一代药物,以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717002548aef9f7d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717002548aef9f7d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ALDX","BK4139"],"gpt_icon":0},{"id":"2444149432","title":"Aldeyra Therapeutics, Inc.盘中异动 急速下跌6.06%报3.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444149432","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444149432?lang=zh_cn&edition=full","pubTime":"2024-06-20 21:31","pubTimestamp":1718890318,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日21时31分,Aldeyra Therapeutics, Inc.股票出现异动,股价快速下跌6.06%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.13%。Aldeyra Therapeutics, Inc.公司简介:Aldeyra Therapeutics Inc是一家生物技术公司,致力于开发和商业化下一代药物,以改善免疫介导疾病患者的生活。消息层面,截至21时31分,《BTIG维持Aldeyra Therapeutics买入评级,维持目标价11美元》资讯为影响Aldeyra Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620213158af8e73df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620213158af8e73df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ALDX","BK4139"],"gpt_icon":0},{"id":"2443609214","title":"Aldeyra Therapeutics, Inc.盘中异动 下午盘股价大跌5.18%报3.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443609214","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2443609214?lang=zh_cn&edition=full","pubTime":"2024-06-15 02:27","pubTimestamp":1718389630,"startTime":"0","endTime":"0","summary":"北京时间2024年06月15日02时27分,Aldeyra Therapeutics, Inc.股票出现异动,股价快速下挫5.18%。截至发稿,该股报3.66美元/股,成交量30.6101万股,换手率0.52%,振幅5.18%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.13%。Aldeyra Therapeutics, Inc.公司简介:Aldeyra Therapeutics Inc是一家生物技术公司,致力于开发和商业化下一代药物,以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615022711af8da6ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615022711af8da6ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALDX","LENZ","BK4139"],"gpt_icon":0},{"id":"2443950938","title":"Aldeyra Therapeutics Inc:临床试验结果和新药申请再次提交预计在2024年下半年公布。","url":"https://stock-news.laohu8.com/highlight/detail?id=2443950938","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2443950938?lang=zh_cn&edition=full","pubTime":"2024-06-13 19:00","pubTimestamp":1718276452,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ALDX","BK1576","BK1141","BK4139","BK1583","03347","LENZ"],"gpt_icon":0},{"id":"2442920552","title":"Aldeyra Therapeutics, Inc.盘中异动 早盘快速上涨5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442920552","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442920552?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:32","pubTimestamp":1718199157,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时32分,Aldeyra Therapeutics, Inc.股票出现波动,股价快速拉升5.54%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.39%。其相关个股中,Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Avidity Biosciences, Inc.、Molecular Partners Ag涨幅较大,Tonix Pharmaceuticals Holding Corp.、Tracon Pharmaceuticals, Inc.、Jaguar Health, Inc.较为活跃,换手率分别为39.19%、19.35%、3.83%,振幅较大的相关个股有Passage Bio, Inc.、Xortx Therapeutics Inc.、Prokidney Corp.,振幅分别为21.10%、20.93%、9.01%。Aldeyra Therapeutics, Inc.公司简介:Aldeyra Therapeutics Inc是一家生物技术公司,致力于开发和商业化下一代药物,以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213237af8d2fa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213237af8d2fa3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALDX","BK4139","LENZ"],"gpt_icon":0},{"id":"2441772162","title":"Aldeyra Therapeutics, Inc.盘中异动 临近收盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441772162","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441772162?lang=zh_cn&edition=full","pubTime":"2024-06-07 03:41","pubTimestamp":1717702873,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日03时41分,Aldeyra Therapeutics, Inc.股票出现波动,股价大幅跳水5.02%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.70%。其相关个股中,Virax Biolabs Group Limited、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Fibrobiologics, Inc.涨幅较大,Virax Biolabs Group Limited、Geovax Labs, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为3299.93%、87.92%、66.99%,振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Virax Biolabs Group Limited、Fibrobiologics, Inc.,振幅分别为129.76%、87.85%、70.00%。Aldeyra Therapeutics, Inc.公司简介:Aldeyra Therapeutics Inc是一家生物技术公司,致力于开发和商业化下一代药物,以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060703411396812a99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060703411396812a99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALDX","LENZ","BK4139"],"gpt_icon":0},{"id":"2440123927","title":"Aldeyra Therapeutics, Inc.盘中异动 早盘快速拉升5.47%报4.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440123927","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440123927?lang=zh_cn&edition=full","pubTime":"2024-06-04 22:23","pubTimestamp":1717511006,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日22时23分,Aldeyra Therapeutics, Inc.股票出现波动,股价急速拉升5.47%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.61%。其相关个股中,Annexon, Inc.、Cingulate Inc C/Wts 10/12/2026 、艾吉纳斯涨幅较大,Bio-Path Holdings, Inc.、Fresh2 Group Limited、Annexon, Inc.较为活跃,换手率分别为58.30%、38.63%、33.39%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Annexon, Inc.、Silo Pharma, Inc.,振幅分别为181.00%、31.22%、28.08%。Aldeyra Therapeutics, Inc.公司简介:Aldeyra Therapeutics Inc是一家生物技术公司,致力于开发和商业化下一代药物,以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060422232796811e50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060422232796811e50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALDX","BK4139","LENZ"],"gpt_icon":0},{"id":"2439558420","title":"Aldeyra Therapeutics, Inc.盘中异动 快速跳水5.12%报3.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439558420","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439558420?lang=zh_cn&edition=full","pubTime":"2024-05-29 03:14","pubTimestamp":1716923676,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日03时14分,Aldeyra Therapeutics, Inc.股票出现异动,股价快速下跌5.12%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.84%。其相关个股中,Insmed Incorporated、Calliditas Therapeutics Ab、Effector Therapeutics Inc C/Wts 31/12/2025 涨幅较大,Mustang Bio, Inc.、Exicure, Inc.、Kintara Therapeutics, Inc.较为活跃,换手率分别为80.13%、62.61%、46.30%,振幅较大的相关个股有Tc Biopharm Plc C/Wts 10/02/2028 、Exicure, Inc.、Biocardia Inc C/Wts 06/08/2024,振幅分别为89.11%、84.85%、52.98%。Aldeyra Therapeutics, Inc.公司简介:Aldeyra Therapeutics Inc是一家生物技术公司,致力于开发和商业化下一代药物,以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529031436aef21fb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529031436aef21fb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALDX","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aldeyra.com","stockEarnings":[{"period":"1week","weight":-0.0253},{"period":"1month","weight":0.14},{"period":"3month","weight":0.5923},{"period":"6month","weight":0.9863},{"period":"1year","weight":-0.1053},{"period":"ytd","weight":0.6467}],"compareEarnings":[{"period":"1week","weight":0.026},{"period":"1month","weight":0.0158},{"period":"3month","weight":0.0266},{"period":"6month","weight":0.0783},{"period":"1year","weight":0.2692},{"period":"ytd","weight":0.1846}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aldeyra Therapeutics, Inc.是一家2004年8月13日成立于特拉华州的神经系统股份有限公司。公司为生物技术公司,专注于开发产品用以治疗免疫介导、相关炎症、罕见病症以及其他与游离醛(一种自然产生的有害化学物质)相关的疾病。Aldeyra Therapeutics正在开发下一代药物,以改善免疫介导疾病患者的生活。 Aldeyra的主要产品候选药物reproxalap是干眼症和其他形式眼炎症晚期发展的一流治疗药物。 Aldeyra还在开发自身免疫性疾病,移植后淋巴组织增生性疾病,视网膜炎症,代谢性疾病和癌症的其他候选产品。 Aldeyra的产品候选人均未获准在美国或其他地方销售。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.077344},{"month":2,"riseRate":0.6,"avgChangeRate":0.000014},{"month":3,"riseRate":0.4,"avgChangeRate":-0.001859},{"month":4,"riseRate":0.5,"avgChangeRate":0.045254},{"month":5,"riseRate":0.4,"avgChangeRate":0.032473},{"month":6,"riseRate":0.272727,"avgChangeRate":-0.035553},{"month":7,"riseRate":0.545455,"avgChangeRate":0.029811},{"month":8,"riseRate":0.454545,"avgChangeRate":0.039547},{"month":9,"riseRate":0.636364,"avgChangeRate":0.201032},{"month":10,"riseRate":0.5,"avgChangeRate":-0.105045},{"month":11,"riseRate":0.7,"avgChangeRate":0.094222},{"month":12,"riseRate":0.4,"avgChangeRate":-0.034658}],"exchange":"NASDAQ","name":"Aldeyra Therapeutics Inc","nameEN":"Aldeyra Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aldeyra Therapeutics Inc(ALDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aldeyra Therapeutics Inc(ALDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aldeyra Therapeutics Inc,ALDX,Aldeyra Therapeutics Inc股票,Aldeyra Therapeutics Inc股票老虎,Aldeyra Therapeutics Inc股票老虎国际,Aldeyra Therapeutics Inc行情,Aldeyra Therapeutics Inc股票行情,Aldeyra Therapeutics Inc股价,Aldeyra Therapeutics Inc股市,Aldeyra Therapeutics Inc股票价格,Aldeyra Therapeutics Inc股票交易,Aldeyra Therapeutics Inc股票购买,Aldeyra Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aldeyra Therapeutics Inc(ALDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aldeyra Therapeutics Inc(ALDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}